Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Positive Development for Bristol-Myers Squibb Company's Breyanzi NHL Treatment

March 19, 2025
Bristol-Myers Squibb Company's groundbreaking NHL treatment, Breyanzi, has received approval from the European Commission (EC) for its use in patients. This approval is a significant milestone for the pharmaceutical company as it expands its reach in the European market. Breyanzi has shown promising results in clinical trials, providing hope for patients with NHL. With this latest development, Bristol-Myers Squibb Company is expected to witness a surge in demand for its innovative treatment. Investors and healthcare professionals are advised to consult the experts at Stocks Prognosis for accurate forecasts on the movement of Bristol-Myers Squibb Company's shares.

Find out how the BRISTOL-MYERS SQUIBB COMPANY rate is expected to change

Get Forecast for BMY

Investor opinions & comments:

I'm looking forward to seeing the impact of Breyanzi in Europe. It has the potential to transform the lives of patients with NHL and offer them new hope for the future
— from FinanceFelix at 03-22-2025 18:18
I'm excited to see the impact Breyanzi will have on patients in Europe. It has shown promising results in clinical trials, so it's fantastic to hear that it has received approval from the European Commission
— from HenryMurphy at 03-21-2025 22:14
The approval of Breyanzi by the European Commission is a testament to the hard work and dedication of the team at Bristol-Myers Squibb Company. This treatment has the potential to make a real difference in the lives of patients with NHL
— from JamesThomas at 03-21-2025 12:48
I'm skeptical about the surge in demand for Breyanzi. Just because it has received approval from the European Commission doesn't necessarily mean that healthcare professionals and patients will immediately embrace it
— from BudgetBobby at 03-21-2025 00:58
I'm not convinced that Breyanzi will live up to the hype. While it may have shown promising results in clinical trials, there's no guarantee that it will be as effective in real-world patient populations
— from InvestorIrene at 03-20-2025 19:57
This approval is a major win for Bristol-Myers Squibb Company. It solidifies their position as a leader in the pharmaceutical industry and demonstrates their commitment to developing groundbreaking treatments
— from MoneyJoe at 03-20-2025 15:44
The approval of Breyanzi in Europe opens up new possibilities for patients with NHL. They now have access to a treatment that has shown promising results and could improve their quality of life
— from LucasPrice at 03-20-2025 11:28
This is great news for patients with NHL! Expanding the availability of Breyanzi in the European market will give more people access to this groundbreaking treatment
— from CashKendra at 03-19-2025 11:56
I'm glad to see that Breyanzi has received approval in Europe. It offers hope for patients with NHL who may not have had many treatment options before
— from CarterPatterson at 03-19-2025 09:46
This approval is a significant milestone for Bristol-Myers Squibb Company. It shows their dedication to developing innovative treatments for patients with NHL and expands their presence in the European market
— from FinanceFelix at 03-19-2025 05:11
If you want to leave a comment, then you need Login or Register





Other news for BMY

BMYMay 14, 2025QuantWave Successfully Achieves Price Target Forecast for Bristol-Myers Squibb Company with 14.06% Profit  ~2 min.

QuantWave, an automated forecasting platform, recently celebrated a significant achievement in its analytics with the successful price target forecast for the stock of BRISTOL-MYERS SQUIBB COMPANY....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits QuantWave Price Target with 13.0% Profit Margin  ~2 min.

On April 11, 2025, QuantWave, an automated forecasting platform, released a short signal for BRISTOL-MYERS SQUIBB COMPANY with a price target forecast of 44.12 $, indicating a 13....

BMYMay 8, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target as QuantWave Forecast Achieves 7.55% Profit  ~1 min.

BRISTOL-MYERS SQUIBB COMPANY has seen its stock reach the predicted price target set by QuantWave's automated forecasting platform....

BMYApril 10, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Forecast Target with 8.57% Profit: A Success Story for QuantWave  ~2 min.

BRISTOL-MYERS SQUIBB COMPANY (BMY) recently reached the price target forecasted by QuantWave, resulting in a profitable outcome for investors....

BMYApril 10, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 8.64% Profit: QuantWave Analysis  ~1 min.

BRISTOL-MYERS SQUIBB COMPANY, a leading pharmaceutical company, recently saw its stock reach the price target forecasted by QuantWave, generating an impressive 8.64% profit for investors....



Related news

REGNJanuary 1, 2025Regeneron Pharmaceuticals Inc. Shows Impressive 89% Return for Investors  ~1 min.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has been making significant strides in the pharmaceutical industry, resulting in a decent 89% return for its investors over the last five years....

REGNJanuary 1, 2025Regeneron Pharmaceuticals, Inc.: Groundbreaking Discoveries in Drug Development  ~2 min.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has made remarkable progress in the field of drug development, delighting its investors with a decent 89% return over the past five years....

PFENovember 21, 2024Pfizer Inc. Introduces Groundbreaking Immunotherapy Treatment, Boosting Confidence in PFE Stock  ~2 min.

Pfizer Inc., a leading pharmaceutical company, has announced the development of a groundbreaking immunotherapy treatment that could revolutionize cancer treatment....

PFENovember 11, 2024Pfizer Inc. Announces Groundbreaking Breakthrough in COVID-19 Treatment  ~2 min.

Pfizer Inc., the renowned pharmaceutical company, has made a groundbreaking discovery in the fight against COVID-19....

GSKJanuary 2, 2025GSK PLC introduces groundbreaking technology to revolutionize healthcare industry  ~2 min.

GSK PLC, a leading pharmaceutical company, has unveiled its latest innovation aimed at transforming the healthcare industry....